32 related articles for article (PubMed ID: 27233813)
1. Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias.
Mandal R; Ghosh I; Banerjee D; Mittal S; Muwonge R; Roy C; Panda C; Vernekar M; Frappart L; Basu P
Int J Gynecol Pathol; 2020 Jul; 39(4):384-390. PubMed ID: 32515923
[TBL] [Abstract][Full Text] [Related]
2. Cervical Intraepithelial Neoplasia grade 2 biopsy: Do p16INK4a and Ki-67 biomarkers contribute to the decision to treat? A cross-sectional study.
Ferreira AL; Dibe ND; Paiva BR; Portari EA; Dock DCA; Ferreira NVC; Gomes Junior SC; Russomano FB; Andrade CV
Sao Paulo Med J; 2023; 142(1):e2022527. PubMed ID: 37646766
[TBL] [Abstract][Full Text] [Related]
3. Mathematical Modelling of Cervical Precancerous Lesion Grade Risk Scores: Linear Regression Analysis of Cellular Protein Biomarkers and Human Papillomavirus
Bumrungthai S; Ekalaksananan T; Kleebkaow P; Pongsawatkul K; Phatnithikul P; Jaikan J; Raumsuk P; Duangjit S; Chuenchai D; Pientong C
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980391
[TBL] [Abstract][Full Text] [Related]
4. Possible role of negative human papillomavirus E6/E7 mRNA as a predictor of regression of cervical intraepithelial neoplasia 2 lesions in hr-HPV positive women.
Bruno MT; Cassaro N; Vitale SG; Guaita A; Boemi S
Virol J; 2022 May; 19(1):95. PubMed ID: 35624470
[TBL] [Abstract][Full Text] [Related]
5. Preliminary Study on the Expression of Testin, p16 and Ki-67 in the Cervical Intraepithelial Neoplasia.
Popiel A; Piotrowska A; Sputa-Grzegrzolka P; Smolarz B; Romanowicz H; Dziegiel P; Podhorska-Okolow M; Kobierzycki C
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440214
[TBL] [Abstract][Full Text] [Related]
6. Analysis of factors affecting the prognosis of patients with cervical intraepithelial neoplasia 2.
Zhang X; Xu Y; Meng T; Shen D
Oncol Lett; 2020 Aug; 20(2):1810-1816. PubMed ID: 32724424
[TBL] [Abstract][Full Text] [Related]
7. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
[TBL] [Abstract][Full Text] [Related]
8. p16 Immunohistochemistry Is Not Always Required For Accurate Diagnosis of Grade 2 Squamous Intraepithelial Lesions.
Sun L; Zhang L; Krigman HR; Hagemann IS
J Low Genit Tract Dis; 2018 Apr; 22(2):104-109. PubMed ID: 29570565
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.
Tainio K; Athanasiou A; Tikkinen KAO; Aaltonen R; Cárdenas J; Hernándes ; Glazer-Livson S; Jakobsson M; Joronen K; Kiviharju M; Louvanto K; Oksjoki S; Tähtinen R; Virtanen S; Nieminen P; Kyrgiou M; Kalliala I
BMJ; 2018 Feb; 360():k499. PubMed ID: 29487049
[TBL] [Abstract][Full Text] [Related]
10. [Nomenclature of squamous cell precursor lesions of the lower female genital tract : Current aspects].
Horn LC; Brambs CE; Handzel R; Mehlhorn G; Schmidt D; Schierle K
Pathologe; 2016 Nov; 37(6):526-533. PubMed ID: 27738814
[TBL] [Abstract][Full Text] [Related]
11. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
Ikenberg H; Bergeron C; Schmidt D; Griesser H; Alameda F; Angeloni C; Bogers J; Dachez R; Denton K; Hariri J; Keller T; von Knebel Doeberitz M; Neumann HH; Puig-Tintore LM; Sideri M; Rehm S; Ridder R;
J Natl Cancer Inst; 2013 Oct; 105(20):1550-7. PubMed ID: 24096620
[TBL] [Abstract][Full Text] [Related]
12. p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia.
Kalof AN; Cooper K
Adv Anat Pathol; 2006 Jul; 13(4):190-4. PubMed ID: 16858153
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of p16, Ki-67 and p53 in cervical lesions - A systematic review.
Silva DC; Gonçalves AK; Cobucci RN; Mendonça RC; Lima PH; Cavalcanti G
Pathol Res Pract; 2017 Jul; 213(7):723-729. PubMed ID: 28554769
[TBL] [Abstract][Full Text] [Related]
14. The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2.
Miyamoto S; Hasegawa J; Morioka M; Hirota Y; Kushima M; Sekizawa A
Int J Gynaecol Obstet; 2016 Jul; 134(1):45-8. PubMed ID: 27233813
[TBL] [Abstract][Full Text] [Related]
15. Variability of pathologists' utilization of p16 and ki-67 immunostaining in the diagnosis of cervical biopsies in routine pathology practice and its impact on the frequencies of cervical intraepithelial neoplasia diagnoses and cytohistologic correlations.
Singh C; Manivel JC; Truskinovsky AM; Savik K; Amirouche S; Holler J; Thyagarajan B; Gulbahce HE; Pambuccian SE
Arch Pathol Lab Med; 2014 Jan; 138(1):76-87. PubMed ID: 24377814
[TBL] [Abstract][Full Text] [Related]
16. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
